Xencor

1 follower


Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.

Industries

Employees

201-500

Links

Org chart

Bassil I. Dahiyat
President, CEO & Director

Bassil I. Dahiyat

Collapse
John R. Desjarlais
EVP, Research & Chief Scientific Officer
Nancy Valente
EVP & Chief Development Officer
John J. Kuch
SVP & CFO
Celia Eckert
SVP, General Counsel & Corporate Secretary
Kirk Rosemark
SVP, Regulatory Affairs & Quality Assurance
Jeremy Grunstein
VP, Business Development
Jennifer Sandoz
VP, Human Resources
Melissa Long
Senior Director, Contracts & Data Privacy
Chet Bohac
Executive Medical Director
Michael Chiarella
Senior Director, Clinical Science
Norman Barlow
Senior Vice President
Jitendra Kanodia
Vice President Head Of Translational
Christine Presco
Sr. Manager, Nonclinical And Bioanalytical Development Project Manager
Heather Gouvis Ms
Executive Director, Oncology Program Leadership And Alliance Management
Tami See
Director, Clinical Data Management